AmplideX® PCR/CE SMN1/2 Plus Kit

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and an SMN2 disease modifier.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in under four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Features & Benefits

Reduced Complexity
  • Similar workflow to AmplideX PCR/CE FMR1*† kit eases implementation and training
  • Multiplexed, scalable design allows analysis of single-nucleotide variants, small indels, and copy-number changes from a single PCR reaction
  • Assay-specific software automates variant calls and streamlines data analysis
Optimized Workflow
  • DNA-to-data in less than four hours with only 60 minutes of hands-on-time
  • Optimized for use on widely installed CE equipment
  • Fully-kitted solution sourced from a single vendor
Quality Results
  • Ability to differentiate between 0, 1, 2, 3 and ≥4 copies for both SMN1 and SMN2
  • Variant reporting automated along with copy number via AmplideX Reporter software
  • Accuracy demonstrated through comparisons with multiple orthogonal methods

*For Research Use Only. Not for use in Diagnostic procedures.
CE-IVD for US Export Only.

Analytical Characteristics

Figure 1. Example Electropherogram Output – AmplideX PCR/CE SMN1/2 Plus Kit

 

Figure 2. AmplideX PCR/CE SMN1/2 Plus Kit Testing Workflow

Additional Resources

Videos

From Two Days to Four Hours: How the AmplideX PCR/CE SMN1/2 Plus Kit Provides SMN1 and SMN2 Copy Number Information and More…

Posters

A Rapid Diagnostic and Screening System for Spinal Muscular Atrophy that Reports Copy Number Changes, Single Nucleotide Variants and Small Indels
View Full Poster

Ordering Information

Product Name Number of Reactions Catalog Number
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 50 A00050
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 100 A00054

T 1-877-777-1874; 512-681-5200
F 512-681-5202
E orders@asuragen.com

AmplideX® PCR/CE SMN1/2 Plus Kit

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and an SMN2 disease modifier.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in under four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Features & Benefits

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and an SMN2 disease modifier.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in under four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Analytical Characteristics

 

 

Additional Resources

 

 

Ordering Information

Product Name Number of Reactions Catalog Number
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 50 A00050
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 100 A00054

T 1-877-777-1874; 512-681-5200
F 512-681-5202
E orders@asuragen.com

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close